Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at New Haven, Connecticut
Dates
study started
estimated completion

Description

Summary

Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid intervention of patients that have a failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions.

Official Title

Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System In Transcarotid Embolectomy

Details

This is a prospective, multi-center, single arm feasibility study for the endovascular treatment of patients with acute ischemic anterior circulation strokes due to large vessel embolic occlusions using the transcarotid approach with flow reversal. Patients enrolled into the NITE 1 Study will have failed transfemoral therapy and will be followed immediately from post-op to 90 days.

Keywords

Acute Ischemic Stroke mechanical thrombectomy stroke treatment embolic protection transcarotid Stroke Ischemic Stroke Cerebral Infarction Ischemia NOVIS Transcarotid Neuroprotection System (NPS)

Eligibility

You can join if…

Open to people ages 18 years and up

Summary:

    1. Patients presenting with acute ischemic stroke of the anterior circulation with large vessel occlusions who are eligible for revascularization using endovascular therapies (stentrievers and/or aspiration devices)
  • Occlusion of the intracranial ICA, MCA M1, proximal MCA M2, single-vessel MCA M2, dominant MCA M2, or co-dominant MCA M2 segments
  • Patient has failed transfemoral therapy (see Appendix 4 for definition), and at least 15 minutes have elapsed from groin puncture

You CAN'T join if...

Summary:

    1. Significant disease of the ipsilateral common carotid artery on routine CTA
  • Presence of a cervical ICA loop or other high-risk anatomical features of the ICA on routine CTA, that may preclude the use of the NOVIS NPS
  • Any active or recent hemorrhage within the past 30 days
  • Embolectomy contraindications
  • Pre-stroke mRS ≥2 b. NIHSS ≤ 5 c. ASPECTS ≤ 5
  • IV tPA has been or is being administered
  • Last known well > 24 hours ago

Location

  • Yale University accepting new patients
    New Haven Connecticut 06511 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Silk Road Medical
Links
Sign up for this study
ID
NCT04881162
Study Type
Interventional
Participants
Expecting 30 study participants
Last Updated